Skip to main content

WHO suspends hydroxychloroquine trials over safety concerns

The World Health Organization says it is temporarily halting its clinical trials that use hydroxychloroquine to treat COVID-19 patients over published concerns that the drug may do more harm than good.
The move comes after the medical journal The Lancet reported on Friday May 22 that patients getting hydroxychloroquine were dying at higher rates than other coronavirus patients.
The WHO has 3,500 patients from 17 countries enrolled in what it calls the Solidarity Trial. This is an effort overseen by the WHO to find new treatments for COVID-19. READ MORE
Labels:

Comments

Post a Comment

Popular posts from this blog

Covid-19 treatment: Algeria to continue using Hydroxychloroquine

Algerian authorities have vowed they will not give up on the controversial use of hydroxychloroquine in the treatment against coronavirus, despite the decision of the World Health Organization ( WHO ) to suspend clinical trials, a member of the Pandemic Monitoring Committee said Tuesday. “We have treated thousands of cases with this drug with great success to date. And we have not noted any adverse reactions,” Dr. Mohamed Bekkat, a member of the Scientific Committee monitoring the evolution of the Covid-19 pandemic in Algeria, told AFP . “We have not recorded any deaths related to the use of (hydroxy)chloroquine,” said Dr. Bekkat, also president of the Council of the Algerian Medical Association. READ MORE
Post a Comment
Read more

On Africa Day, Ramaphosa praises the continent for its ‘swiftness’ in battling Covid-19

The African response to the coronavirus pandemic has received widespread praise. Despite the multitude of resource challenges they face, African countries have come together in remarkable ways, united by a common purpose. The countries of the Global South are more vulnerable to the impacts of COVID-19 because of low levels of development, insufficient resources and weak health systems. READ MORE
Post a Comment
Read more